Skip to content
PIL Logo

XIFAXANTA 200 mg Film-coated Tablets

Last Updated on eMC 01-Feb-2017 View document  | Norgine Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01-Feb-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 23-Jan-2017 and displayed until 01-Feb-2017

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents

Updated on 22-Aug-2016 and displayed until 23-Jan-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 20-Nov-2015 and displayed until 22-Aug-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Improved presentation of PIL
  • Removal of black triangle

Updated on 29-May-2015 and displayed until 20-Nov-2015

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink

Updated on 02-Sep-2011 and displayed until 29-May-2015

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Norgine Limited

Company image
Address

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS

Fax

+44 (0)1895 825 865

Medical Information e-mail
Telephone

+44 (0)1895 826 600

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

rifaximin

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue